Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed - 34 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 1991 adjusted for splits and dividends. The latest closing stock price for Insmed as of August 26, 2025 is 132.17.
  • The all-time high Insmed stock closing price was 760.00 on December 30, 1991.
  • The Insmed 52-week high stock price is 133.56, which is 1.1% above the current share price.
  • The Insmed 52-week low stock price is 60.40, which is 54.3% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 80.51.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 84.8401 69.9500 132.6000 64.8100 132.1700 91.44%
2024 53.5032 29.9400 79.0100 22.0000 69.0400 122.78%
2023 21.8417 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6318 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7275 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1199 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6981 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0217 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7450 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0065 37.5000 89.9000 24.7000 38.2000 10.12%
2000 166.4676 110.0000 455.0000 26.8750 34.6880 -69.84%
1999 57.0461 67.5000 115.0000 33.7520 115.0000 70.37%
1998 77.4331 70.0000 155.0000 20.0000 67.5000 -6.90%
1997 100.8424 82.5000 155.0000 66.2480 72.5000 -9.38%
1996 101.0310 105.0000 157.5000 72.5000 80.0000 -21.95%
1995 83.9087 102.5000 120.0000 50.0000 102.5000 -2.38%
1994 253.8046 445.0000 460.0000 80.0000 105.0000 -76.14%
1993 319.4862 390.0000 445.0000 230.0000 440.0000 10.00%
1992 358.3858 710.0000 720.0000 210.0000 400.0000 -45.21%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $27.124B $0.364B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $247.055B 18.02
Amgen (AMGN) United States $155.301B 13.23
Gilead Sciences (GILD) United States $141.638B 14.75
Vertex Pharmaceuticals (VRTX) United States $99.721B 25.71
Bristol Myers Squibb (BMY) United States $95.950B 7.00
GSK (GSK) United Kingdom $80.738B 9.39
CSL (CSLLY) Australia $67.112B 0.00
Regeneron Pharmaceuticals (REGN) United States $60.665B 14.76
Alnylam Pharmaceuticals (ALNY) United States $58.152B 0.00
Argenex SE (ARGX) Netherlands $41.452B 72.91
BioNTech SE (BNTX) Germany $25.259B 0.00
Royalty Pharma (RPRX) United States $20.988B 8.20
Biogen (BIIB) United States $19.992B 8.52
Incyte (INCY) United States $16.552B 21.08
Genmab (GNMSF) Denmark $16.188B 14.34
Genmab (GMAB) Denmark $15.596B 14.22
Illumina (ILMN) United States $15.318B 23.96
Ascendis Pharma (ASND) Denmark $11.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $11.233B 15.85
Swedish Orphan Biovitrum (BIOVF) Sweden $10.947B 24.21
QIAGEN (QGEN) Netherlands $10.870B 20.84
Exelixis (EXEL) United States $10.203B 18.40
Moderna (MRNA) United States $9.863B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $9.136B 0.00
Bio-Techne Corp (TECH) United States $8.890B 32.78
Exact Sciences (EXAS) United States $8.644B 0.00
Halozyme Therapeutics (HALO) United States $8.446B 14.86
Roivant Sciences (ROIV) United Kingdom $7.949B 0.00
Guardant Health (GH) United States $7.717B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.557B 40.32
Anbio Biotechnology (NNNN) Germany $7.069B 0.00
Repligen (RGEN) United States $6.822B 74.39
Bio-Rad Laboratories (BIO.B) United States $6.723B 24.56
Revolution Medicines (RVMD) United States $6.668B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.589B 0.00
Legend Biotech (LEGN) United States $6.358B 0.00
Abivax SA (ABVX) France $5.854B 0.00
Avidity Biosciences (RNA) United States $5.824B 0.00
Axsome Therapeutics (AXSM) United States $5.804B 0.00
Nuvalent (NUVL) United States $5.339B 0.00
Merus (MRUS) Netherlands $4.972B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.923B 0.00
Alkermes (ALKS) Ireland $4.787B 13.30
Zealand Pharma (ZLDPF) Denmark $4.688B 4.63
TG Therapeutics (TGTX) United States $4.527B 77.11
Cytokinetics (CYTK) United States $4.429B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.272B 39.56
Krystal Biotech (KRYS) United States $4.248B 29.83
Telix Pharmaceuticals (TLX) Australia $4.128B 0.00
ADMA Biologics Inc (ADMA) United States $4.059B 29.33
Ascentage Pharma Group - (AAPG) China $4.042B 0.00
Vaxcyte (PCVX) United States $3.953B 0.00
PTC Therapeutics (PTCT) United States $3.916B 6.50
Zai Lab (ZLAB) United States $3.803B 0.00
Arcellx (ACLX) United States $3.798B 0.00
Akero Therapeutics (AKRO) United States $3.762B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.608B 0.00
Jyong Biotech (MENS) Taiwan $3.573B 0.00
Protagonist Therapeutics (PTGX) United States $3.539B 81.26
MoonLake Immunotherapeutics (MLTX) Switzerland $3.509B 0.00
Apellis Pharmaceuticals (APLS) United States $3.476B 0.00
Metsera (MTSR) United States $3.424B 0.00
Scholar Rock Holding (SRRK) United States $3.204B 0.00
Ligand Pharmaceuticals (LGND) United States $3.112B 0.00
Kymera Therapeutics (KYMR) United States $2.990B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.941B 0.00
Viking Therapeutics (VKTX) United States $2.907B 0.00
Bavarian Nordic (BVNRY) Denmark $2.899B 14.09
Arrowhead Pharmaceuticals (ARWR) United States $2.863B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.821B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.779B 0.00
Immunovant (IMVT) United States $2.596B 0.00
Alvotech (ALVO) Luxembourg $2.508B 18.91
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.449B 826.00
Tarsus Pharmaceuticals (TARS) United States $2.390B 0.00
Amicus Therapeutics (FOLD) United States $2.306B 0.00
Denali Therapeutics (DNLI) United States $2.277B 0.00
Liquidia Technologies (LQDA) United States $2.260B 0.00
IDEAYA Biosciences (IDYA) United States $2.166B 0.00
Agios Pharmaceuticals (AGIO) United States $2.165B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.153B 12.07
ImmunityBio (IBRX) United States $2.127B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.097B 0.00
Celcuity (CELC) United States $2.090B 0.00
Disc Medicine (IRON) United States $2.065B 0.00
Belite Bio (BLTE) United States $2.026B 0.00
Mesoblast (MESO) Australia $2.011B 0.00
ANI Pharmaceuticals (ANIP) United States $1.960B 17.57
CG Oncology (CGON) United States $1.938B 0.00
Adaptive Biotechnologies (ADPT) United States $1.929B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.881B 0.00
Vericel (VCEL) United States $1.806B 298.25
Sarepta Therapeutics (SRPT) United States $1.765B 0.00
Certara (CERT) United States $1.736B 31.79
Apogee Therapeutics (APGE) United States $1.703B 0.00
Beam Therapeutics (BEAM) United States $1.663B 0.00
Twist Bioscience (TWST) United States $1.653B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.642B 0.00
Cidara Therapeutics (CDTX) United States $1.626B 0.00
WAVE Life Sciences (WVE) Singapore $1.582B 0.00
Biohaven (BHVN) United States $1.581B 0.00
Travere Therapeutics (TVTX) United States $1.536B 0.00
Viridian Therapeutics (VRDN) United States $1.516B 0.00
Edgewise Therapeutics (EWTX) United States $1.506B 0.00
Celldex Therapeutics (CLDX) United States $1.456B 0.00
Janux Therapeutics (JANX) United States $1.383B 0.00
Vera Therapeutics (VERA) United States $1.362B 0.00
89BIO (ETNB) United States $1.350B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.349B 0.00
Cogent Biosciences (COGT) United States $1.342B 0.00
NovoCure (NVCR) Jersey $1.308B 0.00
AbCellera Biologics (ABCL) Canada $1.264B 0.00
Pharvaris (PHVS) Netherlands $1.237B 0.00
Intellia Therapeutics (NTLA) United States $1.222B 0.00
Novavax (NVAX) United States $1.221B 3.30
Dynavax Technologies (DVAX) United States $1.218B 51.95
CureVac (CVAC) Germany $1.211B 5.62
MannKind (MNKD) United States $1.197B 35.46
GRAIL (GRAL) United States $1.187B 0.00
Precigen (PGEN) United States $1.186B 0.00
Pacira BioSciences (PCRX) United States $1.139B 12.08
LENZ Therapeutics (LENZ) United States $1.132B 0.00
Zymeworks (ZYME) United States $1.095B 0.00
Arcus Biosciences (RCUS) United States $1.080B 0.00
Structure Therapeutics (GPCR) United States $1.070B 0.00
Sionna Therapeutics (SION) United States $1.062B 0.00
MiMedx (MDXG) United States $1.048B 23.60
Stoke Therapeutics (STOK) United States $1.034B 22.20
CorMedix Inc (CRMD) United States $1.025B 18.31
Spyre Therapeutics (SYRE) United States $1.001B 0.00
Praxis Precision Medicines (PRAX) United States $0.988B 0.00
Nuvation Bio (NUVB) United States $0.986B 0.00
Pharming Group (PHAR) Netherlands $0.978B 0.00
Mineralys Therapeutics (MLYS) United States $0.977B 0.00
Oric Pharmaceuticals (ORIC) United States $0.934B 0.00
Iovance Biotherapeutics (IOVA) United States $0.915B 0.00
Geron (GERN) United States $0.906B 0.00
Upstream Bio (UPB) United States $0.902B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.892B 0.00
Trevi Therapeutics (TRVI) United States $0.887B 0.00
Pharming Group (PHGUF) Netherlands $0.872B 0.00
Immunome (IMNM) United States $0.863B 0.00
Urogen Pharma (URGN) United States $0.856B 0.00
UniQure (QURE) Netherlands $0.853B 0.00
NeoGenomics (NEO) United States $0.833B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.821B 0.00
Anavex Life Sciences (AVXL) United States $0.807B 0.00
Fortrea Holdings (FTRE) United States $0.804B 14.29
Niagen Bioscience (NAGE) United States $0.800B 77.15
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.799B 0.00
Sana Biotechnology (SANA) United States $0.797B 0.00
Gyre Therapeutics (GYRE) United States $0.790B 164.00
ArriVent BioPharma (AVBP) United States $0.785B 0.00
BGM Group (BGM) China $0.781B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.779B 0.00
Oculis Holding AG (OCS) Switzerland $0.777B 0.00
Dianthus Therapeutics (DNTH) United States $0.754B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.749B 0.00
Tango Therapeutics (TNGX) United States $0.748B 0.00
Nurix Therapeutics (NRIX) United States $0.739B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.714B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.713B 0.00
Zenas BioPharma (ZBIO) United States $0.697B 0.00
GH Research (GHRS) Ireland $0.686B 0.00
Arbutus Biopharma (ABUS) United States $0.671B 0.00
Kura Oncology (KURA) United States $0.664B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Tyra Biosciences (TYRA) United States $0.640B 0.00
Immatics (IMTX) Germany $0.636B 0.00
Bicara Therapeutics (BCAX) United States $0.618B 0.00
MeiraGTx Holdings (MGTX) United States $0.610B 0.00
Rezolute (RZLT) United States $0.609B 0.00
Vir Biotechnology (VIR) United States $0.608B 0.00
Keros Therapeutics (KROS) United States $0.599B 47.61
Castle Biosciences (CSTL) United States $0.597B 58.77
Terns Pharmaceuticals (TERN) United States $0.585B 0.00
Maze Therapeutics (MAZE) United States $0.584B 0.00
AnaptysBio (ANAB) United States $0.563B 0.00
Palvella Therapeutics (PVLA) United States $0.554B 0.00
Verastem (VSTM) United States $0.553B 0.00
Arvinas (ARVN) United States $0.549B 0.00
Myriad Genetics (MYGN) United States $0.548B 0.00
Gossamer Bio (GOSS) United States $0.537B 0.00
Rapport Therapeutics (RAPP) United States $0.534B 0.00
Septerna (SEPN) United States $0.533B 0.00
Opthea (OPT) Australia $0.525B 0.00
Cytek Biosciences (CTKB) United States $0.523B 0.00
Alumis (ALMS) United States $0.510B 0.00
ATyr Pharma (ATYR) United States $0.506B 0.00
Kodiak Sciences (KOD) United States $0.500B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.493B 0.00
Emergent Biosolutions (EBS) United States $0.491B 4.02
Arcturus Therapeutics Holdings (ARCT) United States $0.481B 0.00
Prime Medicine (PRME) United States $0.474B 0.00
MBX Biosciences (MBX) United States $0.467B 0.00
PureTech Health (PRTC) United States $0.463B 0.00
Tectonic Therapeutic (TECX) United States $0.460B 0.00
Eton Pharmaceuticals (ETON) United States $0.458B 0.00
REGENXBIO (RGNX) United States $0.453B 0.00
Cullinan Therapeutics (CGEM) United States $0.451B 0.00
Prothena (PRTA) Ireland $0.451B 0.00
Erasca (ERAS) United States $0.451B 0.00
ITeos Therapeutics (ITOS) United States $0.448B 0.00
Inventiva S.A (IVA) France $0.446B 0.00
Solid Biosciences (SLDB) United States $0.436B 0.00
Replimune (REPL) United States $0.429B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.426B 0.00
Compass Therapeutics (CMPX) United States $0.418B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.411B 0.00
XOMA Royalty (XOMA) United States $0.408B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.406B 0.00
Kamada (KMDA) Israel $0.405B 20.74
Aura Biosciences (AURA) United States $0.405B 0.00
I-Mab (IMAB) United States $0.394B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.387B 0.00
Olema Pharmaceuticals (OLMA) United States $0.384B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.382B 0.00
Absci (ABSI) United States $0.380B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.377B 0.00
Inhibrx Biosciences (INBX) United States $0.363B 0.00
Astria Therapeutics (ATXS) United States $0.362B 0.00
Abeona Therapeutics (ABEO) United States $0.359B 7.62
Northwest Biotherapeutics (NWBO) United States $0.357B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.348B 0.00
Benitec Biopharma (BNTC) United States $0.347B 0.00
Fulcrum Therapeutics (FULC) United States $0.347B 0.00
CytomX Therapeutics (CTMX) United States $0.330B 3.57
Amarin (AMRN) Ireland $0.319B 0.00
Candel Therapeutics (CADL) United States $0.313B 0.00
DiaMedica Therapeutics (DMAC) United States $0.310B 0.00
Ocugen (OCGN) United States $0.304B 0.00
Foghorn Therapeutics (FHTX) United States $0.297B 0.00
Design Therapeutics (DSGN) United States $0.296B 0.00
ScPharmaceuticals (SCPH) United States $0.294B 0.00
Bright Minds Biosciences (DRUG) United States $0.294B 0.00
Cartesian Therapeutics (RNAC) United States $0.293B 0.00
Contineum Therapeutics (CTNM) United States $0.291B 0.00
Atea Pharmaceuticals (AVIR) United States $0.290B 0.00
Crescent Biopharma (CBIO) United States $0.287B 0.00
Neurogene (NGNE) United States $0.285B 0.00
Lifecore Biomedical (LFCR) United States $0.284B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.283B 12.75
Mereo BioPharma Group - (MREO) United Kingdom $0.277B 0.00
Tvardi Therapeutics (TVRD) United States $0.274B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.272B 0.00
DBV Technologies S.A (DBVT) France $0.268B 0.00
Neumora Therapeutics (NMRA) United States $0.264B 0.00
Vor Biopharma (VOR) $0.261B 0.00
Jade Biosciences (JBIO) United States $0.258B 0.00
Allogene Therapeutics (ALLO) United States $0.257B 0.00
Puma Biotechnology (PBYI) United States $0.251B 5.09
Prima BioMed (IMMP) Australia $0.250B 0.00
Editas Medicine (EDIT) United States $0.245B 0.00
Codexis (CDXS) United States $0.242B 0.00
Adherex Technologies (FENC) United States $0.241B 0.00
Alpha Teknova (TKNO) United States $0.240B 0.00
Humacyte (HUMA) United States $0.238B 0.00
Alector (ALEC) United States $0.237B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.237B 0.00
Annexon (ANNX) United States $0.236B 0.00
Cognition Therapeutics (CGTX) United States $0.234B 0.00
Sagimet Biosciences (SGMT) United States $0.230B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.229B 0.00
EnGene Holdings (ENGN) Canada $0.220B 0.00
Immuneering (IMRX) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Entrada Therapeutics (TRDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.212B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Innate Pharma S.A (IPHA) France $0.206B 0.00
SELLAS Life Sciences (SLS) United States $0.201B 0.00
Aardvark Therapeutics (AARD) United States $0.196B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.188B 0.00
Monopar Therapeutics (MNPR) United States $0.188B 0.00
Voyager Therapeutics (VYGR) United States $0.185B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.185B 0.00
BridgeBio Oncology Therapeutics (BBOT) United States $0.184B 0.00
Ventyx Biosciences (VTYX) United States $0.181B 0.00
Tevogen Bio Holdings (TVGN) United States $0.181B 0.00
Elicio Therapeutics (ELTX) United States $0.180B 0.00
C4 Therapeutics (CCCC) United States $0.180B 0.00
Rapt Therapeutics (RAPT) United States $0.180B 0.00
Caribou Biosciences (CRBU) United States $0.175B 0.00
Tenaya Therapeutics (TNYA) United States $0.174B 0.00
Instil Bio (TIL) United States $0.174B 0.00
Molecular Partners AG (MOLN) Switzerland $0.170B 0.00
Seres Therapeutics (MCRB) United States $0.168B 0.00
Climb Bio (CLYM) United States $0.168B 0.00
Sangamo Therapeutics (SGMO) United States $0.166B 0.00
Actuate Therapeutics (ACTU) United States $0.166B 0.00
Nuvectis Pharma (NVCT) United States $0.165B 0.00
Kyverna Therapeutics (KYTX) United States $0.165B 0.00
Black Diamond Therapeutics (BDTX) United States $0.163B 12.48
Greenwich LifeSciences (GLSI) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Nkarta (NKTX) United States $0.156B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.154B 0.00
Cellectis S.A (CLLS) France $0.150B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
MaxCyte (MXCT) United States $0.148B 0.00
Citius Oncology (CTOR) United States $0.148B 0.00
TuHURA Biosciences (HURA) United States $0.148B 0.00
Cardiff Oncology (CRDF) United States $0.147B 0.00
Cabaletta Bio (CABA) United States $0.145B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.144B 0.00
Genelux (GNLX) United States $0.141B 0.00
Forte Biosciences (FBRX) United States $0.141B 0.00
Agenus (AGEN) United States $0.140B 0.00
BioHarvest Sciences (BHST) Canada $0.136B 0.00
Coherus Oncology (CHRS) United States $0.136B 0.00
Zura Bio (ZURA) United States $0.133B 0.00
Oncobiologics (OTLK) United States $0.132B 0.00
Anika Therapeutics (ANIK) United States $0.132B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.131B 0.00
Compugen (CGEN) Israel $0.128B 0.00
Scilex Holding (SCLX) United States $0.127B 0.00
Fate Therapeutics (FATE) United States $0.126B 0.00
Alpha Cognition (ACOG) Canada $0.125B 0.00
Seer (SEER) United States $0.118B 0.00
Equillium (EQ) United States $0.113B 0.00
IO Biotech (IOBT) Denmark $0.113B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.111B 0.00
Adagene (ADAG) China $0.111B 0.00
Skye Bioscience (SKYE) United States $0.110B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
TScan Therapeutics (TCRX) United States $0.108B 0.00
Biomea Fusion (BMEA) United States $0.108B 0.00
Alto Neuroscience (ANRO) United States $0.107B 0.00
HilleVax (HLVX) United States $0.106B 0.00
23andMe Holding (MEHCQ) United States $0.105B 0.00
Connect Biopharma Holdings (CNTB) United States $0.104B 0.00
Spero Therapeutics (SPRO) United States $0.104B 0.00
Inovio Pharmaceuticals (INO) United States $0.104B 0.00
Elutia (ELUT) United States $0.101B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.100B 0.00
Oncolytics Biotech (ONCY) Canada $0.099B 0.00
XBiotech (XBIT) United States $0.098B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.097B 0.00
BioStem Technologies (BSEM) $0.096B 5.04
Prenetics Global (PRE) Hong Kong, SAR China $0.095B 0.00
VistaGen Therapeutics (VTGN) United States $0.093B 0.00
Celularity (CELU) United States $0.092B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.091B 0.00
OKYO Pharma (OKYO) $0.091B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Entera Bio (ENTX) Israel $0.089B 0.00
CervoMed (CRVO) United States $0.087B 0.00
Immunic (IMUX) United States $0.087B 0.00
Atara Biotherapeutics (ATRA) United States $0.086B 0.00
Quince Therapeutics (QNCX) United States $0.085B 0.00
BioXcel Therapeutics (BTAI) United States $0.083B 0.00
EXoZymes (EXOZ) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Whitehawk Therapeutics (WHWK) United States $0.080B 0.00
Applied Therapeutics (APLT) United States $0.074B 0.00
BeyondSpring (BYSI) United States $0.073B 0.00
TELA Bio (TELA) United States $0.073B 0.00
Sutro Biopharma (STRO) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.069B 0.00
Opus Genetics (IRD) United States $0.069B 0.00
Artiva Biotherapeutics (ARTV) United States $0.069B 0.00
ZIVO Bioscience (ZIVO) United States $0.069B 0.00
Quantum Biopharma (QNTM) Canada $0.069B 0.00
Fortress Biotech (FBIO) United States $0.068B 0.00
Repare Therapeutics (RPTX) Canada $0.068B 0.00
Invivyd (IVVD) United States $0.067B 0.00
MiNK Therapeutics (INKT) United States $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.066B 0.00
MediciNova (MNOV) United States $0.065B 0.00
Genenta Science S.p.A (GNTA) Italy $0.064B 0.00
Adverum Biotechnologies (ADVM) United States $0.063B 0.00
Cue Biopharma (CUE) United States $0.063B 0.00
Aligos Therapeutics (ALGS) United States $0.063B 0.00
Werewolf Therapeutics (HOWL) United States $0.063B 0.00
InflaRx (IFRX) Germany $0.062B 0.00
KALA BIO (KALA) United States $0.062B 0.00
PDS Biotechnology (PDSB) United States $0.061B 0.00
Immix Biopharma (IMMX) United States $0.061B 0.00
Adlai Nortye (ANL) Cayman Islands $0.061B 0.00
Precision BioSciences (DTIL) United States $0.060B 0.00
INmune Bio (INMB) United States $0.060B 0.00
Adicet Bio (ACET) United States $0.059B 0.00
ALX Oncology Holdings (ALXO) United States $0.059B 0.00
ImageneBio (IMA) United States $0.057B 0.00
Earth Science Tech (ETST) United States $0.057B 0.00
Clene (CLNN) United States $0.053B 0.00
Lantern Pharma (LTRN) United States $0.049B 0.00
VTv Therapeutics (VTVT) United States $0.049B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.049B 0.00
Jasper Therapeutics (JSPR) United States $0.048B 0.00
Shattuck Labs (STTK) United States $0.048B 0.00
Kalaris Therapeutics (KLRS) United States $0.047B 0.00
X4 Pharmaceuticals (XFOR) United States $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.045B 0.00
Grace Therapeutics (GRCE) Canada $0.045B 0.00
Radiopharm Theranostics - (RADX) Australia $0.044B 0.00
Annovis Bio (ANVS) United States $0.044B 0.00
Rani Therapeutics Holdings (RANI) United States $0.043B 0.00
Pluri (PLUR) Israel $0.043B 0.00
PepGen (PEPG) United States $0.043B 0.00
Senti Biosciences (SNTI) United States $0.042B 0.00
Generation Bio (GBIO) United States $0.041B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Renovaro (RENB) United States $0.039B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.039B 0.00
CalciMedica (CALC) United States $0.039B 0.00
Medicus Pharma (MDCX) United States $0.039B 0.00
Mersana Therapeutics (MRSN) United States $0.038B 0.00
OnKure Therapeutics (OKUR) United States $0.038B 0.00
Exicure (XCUR) United States $0.037B 0.00
Xilio Therapeutics (XLO) United States $0.036B 0.00
Estrella Immunopharma (ESLA) United States $0.036B 0.00
Tharimmune (THAR) United States $0.036B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.033B 0.00
RenovoRx (RNXT) United States $0.033B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
Dyadic (DYAI) United States $0.031B 0.00
CAMP4 Therapeutics (CAMP) United States $0.031B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Kezar Life Sciences (KZR) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Promis Neurosciences (PMN) Canada $0.028B 0.00
Rein Therapeutics (RNTX) United States $0.028B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.027B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.027B 0.00
Tenax Therapeutics (TENX) United States $0.027B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Synaptogenix (TAOX) United States $0.024B 0.00
Rallybio (RLYB) United States $0.024B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.024B 0.00
Q32 Bio (QTTB) United States $0.024B 0.00
Passage Bio (PASG) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.023B 0.00
Cingulate (CING) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.022B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Curis (CRIS) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Lexaria Bioscience (LEXX) Canada $0.021B 0.00
Abpro Holdings (ABP) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.019B 0.00
180 Life Sciences (ETHZ) United States $0.019B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
LakeShore Biopharma (LSB) China $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.017B 0.00
Femasys (FEMY) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Chemomab Therapeutics (CMMB) Israel $0.016B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Cocrystal Pharma (COCP) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.016B 0.00
Imunon (IMNN) United States $0.016B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.015B 0.00
Intensity Therapeutics (INTS) United States $0.015B 0.00
NextCure (NXTC) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Allarity Therapeutics (ALLR) United States $0.014B 0.00
Soligenix (SNGX) United States $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
Gelteq (GELS) Australia $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
HCW Biologics (HCWB) United States $0.012B 0.00
Beyond Air (XAIR) United States $0.012B 0.00
Longeveron (LGVN) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.010B 0.00
Advanced Biomed (ADVB) United States $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
IN8bio (INAB) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Biofrontera (BFRI) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
COSCIENS Biopharma (CSCI) Canada $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Mainz Biomed (MYNZ) Germany $0.008B 0.00
Novogen (KZIA) Australia $0.008B 0.00
BioAffinity Technologies (BIAF) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Artelo Biosciences (ARTL) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Aptevo Therapeutics (APVO) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Psyence Biomedical (PBM) Canada $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
GENPREX (GNPX) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.005B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Bone Biologics (BBLG) United States $0.004B 0.00
GT Biopharma (GTBP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00